Document is current
Any future updates will be listed below
-
Authors
Shubow, Sophie
Gunsior, Michele
Rosenberg, Amy
Wang, Yow-Ming
Altepeter, Tara
Guinn, Daphne
Rajabiabhari, Mohsen
Kotarek, Joseph
Mould, Diane R.
Zhou, Honghui
Cheifetz, Adam S.
Garces, Sandra
Chevalier, Rachel
Gavan, Sean
Trusheim, Mark R.
Rispens, Theo
Bray, Kurtis
Partridge, Michael A. https://orcid.org/0000-0001-6699-8473
- License Information
-
More Information
Article History
Received: 2 January 2025
Accepted: 23 February 2025
First Online: 14 March 2025
Declarations
:
: The views expressed in this article are those of the authors and do not necessarily reflect the official views of the FDA.
: ASC has received consulting fees from Abbvie, Aegirbio (SAB), Artizan (SAB), Prometheus (SAB), Fzata, Adiso, BMS, Clario, Food is Good, Fresenius Kabi, Janssen, Lilly, Pfizer, Procise, Spherix, Samsung; and speaking fees (non-branded) from Abbvie, BMS, Janssen. MRT has received consulting fees from Boehringer Ingelheim, Janssen Pharmaceuticals, Merck, Pfizer, Roche Pharmaceuticals, UniQure. DRM is president of Projections Research Inc, a consulting company working with the pharmaceutical industry. The remaining authors report no conflict of interest.
